Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 058757/0359 | |
| Pages: | 7 |
| | Recorded: | 01/25/2022 | | |
Attorney Dkt #: | 754593 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17429391
|
Filing Dt:
|
08/09/2021
|
Publication #:
|
|
Pub Dt:
|
04/28/2022
| | | | |
Title:
|
GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES
|
|
Assignee
|
|
|
OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH |
6701 ROCKLEDGE DRIVE, SUITE 700, MSC 7788 |
BETHESDA, MARYLAND 20892-7788 |
|
Correspondence name and address
|
|
LEYDIG, VOIT & MAYER, LTD.
|
|
TWO PRUDENTIAL PLAZA, SUITE 4900
|
|
180 NORTH STETSON AVENUE
|
|
CHICAGO, IL 60601-6731
|
Search Results as of:
09/25/2024 10:02 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|